Bilateral Pneumothorax and Pazopanib
DOI:
https://doi.org/10.24950/Imagem/22/20/3/2020Keywords:
Pneumothorax/chemically induced, Pazopanib/adverse effectsDownloads
References
Sahn SA, Heffner JE. Spontaneous pnemothorax. N Engl J Med. 2000;342:868.
Celik B, Surucu ZP et al. A case report of secondary simultaneous bilateral pneumothorax due to pazopanib treatment. Turk Thorac J. 2018; 19: 45-51.
Sabath B, Muhammad HA, Balagani A, Ost DE, Vakil E, Ahmed T, et al. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study. BMC Cancer. 2018;18:937. doi: 10.1186/s12885-018-4858-8.
Nakano K, Motoi N, Tomomatsu J, Gokita T, Ae K, Tanizawa T, et al. Risk factors for Pneumothorax In advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis. BMC Cancer.2016. ;16:750. doi: 10.1186/s12885-016-2786-z.
Nakahara Y, Fukui T, Katono K, Nishizawa Y, Okuma Y, Ikegami M, et al. Pneumothorax during pazopanib treatment in patients with soft-tissue sarcoma: two case reports and a review of the literature. Case Rep Oncol.
; 10: 333-8. doi: 10.1159/000463380.
Nakano K, Inagaki L, Tomoatsu J, Motoi N, Gokita T, Ae K, et al. Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment. Clin Oncol. 2014;26:357. doi:
1016/j.clon.2014.02.010.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
